Trial intelligence / Profile preview

EV71 Inactivated Vaccine (Vero Cell) 5-year Immunity Persistence Study in Chinese Infants

CTR20212613Phase 4Completed

Sponsor
Wuhan Institute of Biological Products
Start
Oct 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Inactivated Enterovirus Type 71 Vaccine (Vero Cell), sponsored by Wuhan Institute of Biological Products. Started Oct 2021; status: completed.

02

Drugs

Inactivated Enterovirus Type 71 Vaccine (Vero Cell)

Beyond the preview

Go deeper on CTR20212613.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20212613.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call